PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma

被引：25
|
作者：
Yyu, Dongsheng [1 ]
Wang, Anxun [2 ]
Huang, Hongzhang [1 ]
Chen, Yiyang [1 ]
机构：
[1] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Coll Stomatol, Guangzhou 510055, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Guangzhou 510080, Guangdong, Peoples R China
来源：
NANOMEDICINE | 2008年 / 3卷 / 06期
关键词：
ganciclovir; gene therapy; golden hamster; herpes simplex virus thymidine kinase; nanoparticles; oral squamous cell carcinoma; poly-gamma-benzyl-L-glutamate; polyethylene-glycol;
D O I：
10.2217/17435889.3.6.813
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aims: Previous studies revealed that drug-loaded poly(ethylene-glycol)-poly(gamma-benzyl-L-glutamate) (PEG-PBLG) nanoparticles exhibit favorable pharmacokinetic characteristics in the treatment of oral squamous cell carcinoma (OSCC). In this study, the characteristics and anticancer effect of herpes simplex virus thymidine kinase (HSV-TK)-loaded PEG-PBLG nanoparticles for OSCC were investigated. Materials & methods: HSV-TK-loaded PEG-PBLG nanoparticles were prepared and their morphology, DNA protection and gene-transfer efficiency were evaluated. Their anticancer effect in vitro and in vivo was determined. Results & discussion: HSV-TK-loaded PEG-PBLG nanoparticles have a core-shell structure and DNA protection and higher genetransfer efficiency. PEG-PBLG nanoparticle-mediated HSV-TK/ganciclovir(GCV) had a strong anticancer effect on Tca8113 cells in vitro and buccal carcinoma induced in golden hamsters. Conclusion: PEG-PBLG nanoparticles may be a superior gene carrier in future clinical applications because of their DNA protection and higher gene-transfer efficiency. The HSV-TK/GCV suicide-gene system had significant antitumor effects on OSCC.
引用
收藏
页码：813 / 821
页数：9
相关论文
共 50 条
  • [31] The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells
    Zeng, Zhao-Jun
    Xiang, Sheng-Guang
    Xue, Wei-Wen
    Li, Hong-De
    Ma, Nan
    Ren, Zi-Jing
    Xu, Zhu-Jun
    Jiao, Chun-Hong
    Wang, Cui-Yun
    Hu, Wei-Xin
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (07) : 887 - 892
  • [32] Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells
    Suzuki, T
    Tadakuma, T
    Kunitomi, M
    Takayama, E
    Sato, M
    Asano, T
    Nakamura, H
    Hayakawa, M
    UROLOGIA INTERNATIONALIS, 2001, 67 (03) : 216 - 223
  • [33] The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice
    Kalevi Juhani Pulkkanen
    Johanna M Laukkanen
    Jonas Fuxe
    Mikko I Kettunen
    Marko Rehn
    Jani M Kannasto
    Jyrki J Parkkinen
    Risto A Kauppinen
    Ralf F Pettersson
    Seppo Yla-Herttuala
    Cancer Gene Therapy, 2002, 9 : 908 - 916
  • [34] GENE THERAPY IN ORAL SQUAMOUS CELL CARCINOMA - A SHORT REVIEW
    Sunil, P. M.
    Joseph, Isaac
    Varghese, Soma Susan
    ORAL & MAXILLOFACIAL PATHOLOGY JOURNAL, 2011, 2 (02) : 142 - 147
  • [35] The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice
    Pulkkanen, KJ
    Laukkanen, JM
    Fuxe, J
    Kettunen, MI
    Rehn, M
    Kannasto, JM
    Parkkinen, JJ
    Kauppinen, RA
    Pettersson, RF
    Yla-Herttuala, S
    CANCER GENE THERAPY, 2002, 9 (11) : 908 - 916
  • [36] β2-Adrenergic receptor agonist enhances the bystander effect of HSV-TK/GCV gene therapy in glioblastoma multiforme via upregulation of connexin 43 expression
    Hosseindoost, Saereh
    Mousavi, Seyed Mojtaba
    Dehpour, Ahmad Reza
    Javadi, Seyed Amirhossein
    Arjmand, Babak
    Fallah, Ali
    Hadjighassem, Mahmoudreza
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 26 : 76 - 87
  • [37] Combined treatment of cholangiocarcinoma with interventional radiofrequency hyperthermia and heat shock protein promoter-mediated HSV-TK gene therapy
    Luo, Jingfeng
    Zhou, Jiali
    Xie, Fengnan
    Zhu, Yali
    Zhou, Fei
    Zhang, Shuanglin
    Jiang, Shaojie
    He, Jie
    Liu, Jiaxin
    Wu, Xia
    Zhang, Yanhua
    Sun, Jihong
    Yang, Xiaoming
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (08): : 1595 - 1603
  • [38] Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer
    Y Nasu
    CH Bangma
    GW Hull
    G Yang
    J Wang
    S Shimura
    MA McCurdy
    S Ebara
    H-M Lee
    TL Timme
    TC Thompson
    Prostate Cancer and Prostatic Diseases, 2001, 4 : 44 - 55
  • [39] Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
    Zheng, Qi Chang
    Jiang, Shuai
    Wu, Yu Zhe
    Shang, Dan
    Zhang, Yong
    Hu, Shao Bo
    Cheng, Xiang
    Zhang, Chen
    Sun, Ping
    Gao, Yang
    Song, Zi Fang
    Li, Min
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [40] Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma
    Jiang, Gaofeng
    Li, Jinlong
    Zeng, Zhaolei
    Xian, Lijian
    CANCER BIOLOGY & THERAPY, 2006, 5 (04) : 435 - 440
12345